Q&A with Timber Pharmaceuticals CEO John Koconis: Timber Pharma's Robust Pipeline: Uniquely Focused on Orphan Dermatology Conditions

Covid Q&A with Soligenix SCO Dr Oreola Donini: Medinvest Post Conference Discussion

Q&A with Soligenix (SNGX) CEO Dr. Christopher Schaber